The earnings call highlighted several concerns: a 9% YoY revenue decline, increased R&D expenses, and competitive pressures. Despite a slight gross margin improvement, the overall financial performance was weak. The Q&A section did not provide clarity on strategic initiatives or risk mitigation. These factors, combined with potential supply chain disruptions and regulatory hurdles, suggest a negative market reaction.